Income Statement SurModics

Stocks

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 08:00:00 19/11/25 am AEDT			5-day change	1st Jan Change
42.98 ^USD	+0.35%		-.--%	-

19/05	Endologix LLC acquired Pounce? Thrombectomy System from Surmodics, Inc.	CI
10/12	Surmodics, Inc. acquired certain assets from Biocoat, Incorporated.	CI

338f82ebbd1619ab8745a810ef9b3.vIdfXAT39OB0M6m_NRXwF6_fatf27DhLZAXz7MiZZ6g.0LY1aVuhrLgfd93GWGaVL56PEu-DvUscHHempo3wLO2P_zcZfrG8hDZLxg

Published financial data: SURMODICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Revenues	94.86M	105M	99.95M	133M	126M
Total Revenues	94.86M	105M	99.95M	133M	126M
Cost of Goods Sold, Total	65.5M	66.61M	70.95M	24.96M	33.03M
Gross Profit	29.36M	38.52M	29M	108M	93.05M
Selling General & Admin Expenses, Total	28.39M	31.58M	46.94M	51.88M	53.14M
R&D Expenses	-	-	-	46.6M	38.36M
Amortization of Goodwill and Intangible Assets - (IS)	2.22M	2.79M	4.15M	3.54M	3.5M
Other Operating Expenses, Total	30.61M	34.37M	51.08M	102M	95M
Operating Income	-1.25M	4.16M	-22.08M	5.6M	-1.94M
Interest Expense, Total	-133K	-310K	-598K	-3.49M	-3.54M
Interest And Investment Income	656K	123K	99K	1.08M	1.92M
Net Interest Expenses	523K	-187K	-499K	-2.41M	-1.62M
Currency Exchange Gains (Loss)	-248K	-170K	103K	-251K	-243K
Other Non Operating Income (Expenses)	1K	-	-	-	-
EBT, Excl. Unusual Items	-975K	3.8M	-22.48M	2.94M	-3.81M
Restructuring Charges	-	-	-	-1.28M	-
Merger & Related Restructuring Charges	-	-1.05M	-	-	-3.7M
Gain (Loss) On Sale Of Investments	-479K	-	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	3.6M	-12K	829K	-
EBT, Incl. Unusual Items	-1.45M	6.35M	-22.49M	2.49M	-7.51M
Income Tax Expense	-2.58M	2.11M	4.78M	4.02M	4.04M
Earnings From Continuing Operations	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Net Income to Company	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Net Income - (IS)	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Net Income to Common Incl Extra Items	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Net Income to Common Excl. Extra Items	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Per Share Items
Net EPS - Basic	0.08	0.31	-1.96	-0.11	-0.82
Basic EPS - Continuing Operations	0.08	0.31	-1.96	-0.11	-0.82
Basic Weighted Average Shares Outstanding	13.55M	13.76M	13.92M	14.03M	14.15M
Net EPS - Diluted	0.08	0.3	-1.96	-0.11	-0.82
Diluted EPS - Continuing Operations	0.08	0.3	-1.96	-0.11	-0.82
Diluted Weighted Average Shares Outstanding	13.81M	13.99M	13.92M	14.03M	14.15M
Normalized Basic EPS	-0.04	0.17	-1.01	0.13	-0.17
Normalized Diluted EPS	-0.04	0.17	-1.01	0.13	-0.17
Supplemental Items
EBITDA	6.01M	12.17M	-12.94M	14.12M	6.75M
EBITA	1.25M	7.26M	-17.68M	9.4M	1.86M
EBIT	-1.25M	4.16M	-22.08M	5.6M	-1.94M
EBITDAR	6.61M	12.97M	-11.84M	15.52M	8.35M
Total Revenues (As Reported)	94.86M	105M	99.95M	133M	126M
Effective Tax Rate - (Ratio)	177.24	33.23	-21.26	161.76	-53.77
Current Domestic Taxes	-1.53M	371K	-653K	3.95M	4.14M
Current Foreign Taxes	90K	87K	166K	250K	215K
Total Current Taxes	-1.44M	458K	-487K	4.2M	4.36M
Deferred Domestic Taxes	-1.14M	1.79M	5.72M	-	-
Deferred Foreign Taxes	-	-138K	-447K	-181K	-320K
Total Deferred Taxes	-1.14M	1.65M	5.27M	-181K	-320K
Normalized Net Income	-609K	2.37M	-14.05M	1.84M	-2.38M
Interest on Long-Term Debt	133K	-	598K	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	50.19M	46.73M	50.61M	46.6M	38.36M
Net Rental Expense, Total	600K	800K	1.1M	1.4M	1.6M
Imputed Operating Lease Interest Expense	-	227K	369K	1.63M	1.36M
Imputed Operating Lease Depreciation	-	573K	731K	-226K	237K
Stock-Based Comp., COGS (Total)	1.02M	1.42M	1.66M	279K	282K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	1.42M	1.52M
Stock-Based Comp., SG&A Exp. (Total)	4.44M	4.44M	5.4M	5.91M	6.42M
Total Stock-Based Compensation	5.45M	5.86M	7.06M	7.6M	8.22M

Fiscal Period: September	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	30.78M	31.15M	19M	41.42M	36.12M
Short Term Investments	30.31M	7.72M	-	3.93M	4M
Total Cash And Short Term Investments	61.1M	38.87M	19M	45.35M	40.11M
Accounts Receivable, Total	13.78M	16.26M	17.57M	18.65M	23.16M
Other Receivables	2.39M	6.65M	6.63M	5.25M	108K
Total Receivables	16.17M	22.91M	24.2M	23.9M	23.27M
Inventory	5.97M	6.76M	11.82M	14.84M	15.17M
Prepaid Expenses	3.37M	1.71M	2.57M	2.6M	2.75M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Total Current Assets	86.61M	70.26M	57.59M	86.69M	81.3M
Gross Property Plant And Equipment	75.57M	80.24M	82.1M	85.48M	89.79M
Accumulated Depreciation	-42.96M	-47.72M	-51.32M	-56.47M	-61.8M
Net Property Plant And Equipment	32.61M	32.52M	30.78M	29.01M	27.98M
Long-term Investments	-	2M	-	-	-
Goodwill	27.18M	45.61M	40.71M	42.95M	44.64M
Other Intangibles, Total	13.28M	37.05M	28.14M	26.21M	23.57M
Accounts Receivable Long-Term	-	-	-	-	689K
Deferred Tax Assets Long-Term	7.32M	5.87M	-	-	-
Other Long-Term Assets, Total	1.76M	1.28M	1.14M	877K	376K
Total Assets	169M	195M	158M	186M	179M
Liabilities
Accounts Payable, Total	1.52M	1.78M	3.14M	2.99M	2.79M
Accrued Expenses, Total	10M	12.24M	12.84M	13.05M	13.85M
Short-term Borrowings	-	10M	10M	-	-
Current Portion of Leases	436K	518K	963K	872K	1.04M
Current Income Taxes Payable	-	-	-	-	1.24M
Unearned Revenue Current, Total	5.2M	4.65M	4.16M	4.38M	1.62M
Other Current Liabilities	1.74M	629K	981K	2.66M	-
Total Current Liabilities	18.89M	29.82M	32.08M	23.95M	20.54M
Long-Term Debt	-	-	-	29.4M	29.55M
Long-Term Leases	3.34M	3.19M	3.84M	2.97M	2.65M
Unearned Revenue Non Current	10.8M	10.3M	5.09M	2.4M	-
Deferred Tax Liability Non Current	-	2.74M	2.03M	2M	1.78M
Other Non Current Liabilities	4.68M	8.46M	6.93M	5.09M	5.14M
Total Liabilities	37.71M	54.51M	49.97M	65.82M	59.66M
Common Stock, Total	684K	695K	701K	708K	716K
Additional Paid In Capital	15.37M	21.6M	28.77M	36.71M	44.59M
Retained Earnings	112M	116M	88.79M	87.26M	75.71M
Comprehensive Income and Other	3.17M	1.73M	-9.87M	-4.76M	-2.13M
Total Common Equity	131M	140M	108M	120M	119M
Total Equity	131M	140M	108M	120M	119M
Total Liabilities And Equity	169M	195M	158M	186M	179M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.68M	13.9M	14.04M	14.16M	14.33M
ECS Total Common Shares Outstanding	13.67M	13.9M	14.03M	14.16M	14.32M
Book Value / Share	9.59	10.08	7.73	8.47	8.3
Tangible Book Value	90.59M	57.42M	39.54M	50.76M	50.69M
Tangible Book Value Per Share	6.63	4.13	2.82	3.59	3.54
Total Debt	3.78M	13.71M	14.81M	33.25M	33.24M
Net Debt	-57.32M	-25.16M	-4.19M	-12.1M	-6.87M
Debt Equivalent Oper. Leases	4.8M	6.4M	8.8M	11.2M	12.8M
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Raw Materials, Total	3.76M	4.16M	6.1M	8.06M	8.5M
Inventories - Work In Process, Total	817K	1.3M	1.6M	2.61M	2.48M
Inventories - Finished Goods, Total	1.39M	1.3M	4.12M	4.17M	4.19M
Land - (BS)	4.42M	4.42M	4.41M	4.41M	4.42M
Buildings, Total	25.64M	26.57M	26.37M	26.96M	29.49M
Machinery, Total	35.93M	38.2M	38.02M	42.68M	44.88M
Full Time Employees	370	389	447	376	389
Accumulated Allowance for Doubtful Accounts (Supple)	130K	119K	81K	80K	144K

Fiscal Period: September	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	1.12M	4.24M	-27.27M	-1.54M	-11.54M
Depreciation & Amortization - CF	4.76M	4.92M	4.74M	4.72M	4.89M
Amortization of Goodwill and Intangible Assets - (CF)	2.5M	3.1M	4.4M	3.8M	3.8M
Depreciation & Amortization, Total	7.26M	8.02M	9.14M	8.52M	8.69M
Amortization of Deferred Charges, Total - (CF)	-	-	-	365K	303K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	479K	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	5.45M	5.86M	7.06M	7.6M	8.22M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	73K	-11K	5K	37K	64K
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-1.5M	2.14M	6.12M	-243K	-129K
Change In Accounts Receivable	3.46M	-2.48M	-1.52M	-977K	-5.24M
Change In Inventories	-1.38M	-818K	-5.06M	-3.02M	-328K
Change In Accounts Payable	-483K	264K	1.61M	-183K	-232K
Change in Unearned Revenues	-1.18M	-1.05M	-5.7M	-2.47M	-5.16M
Change In Income Taxes	-1.56M	210K	-1.07M	3.44M	1.58M
Change in Other Net Operating Assets	2.26M	-985K	-533K	-1.02M	4.02M
Cash from Operations	14.01M	15.39M	-17.22M	10.51M	248K
Capital Expenditure	-3.67M	-5.28M	-3.37M	-2.92M	-3.49M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-39.55M	-	-	-
Sale (Purchase) of Intangible assets	-	-1M	-	-	-
Investment in Marketable and Equity Securities, Total	-5.4M	20.59M	9.6M	-3.9M	555K
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-9.07M	-25.24M	6.23M	-6.82M	-2.94M
Short Term Debt Issued, Total	-	10M	-	-	-
Long-Term Debt Issued, Total	-	-	-	29.66M	-
Total Debt Issued	-	10M	-	29.66M	-
Short Term Debt Repaid, Total	-	-	-	-10M	-
Total Debt Repaid	-	-	-	-10M	-
Issuance of Common Stock	1.62M	3.13M	1.25M	1.25M	1.22M
Repurchase of Common Stock	-2.53M	-2.75M	-1.12M	-918K	-1.54M
Other Financing Activities, Total	-3.73M	-150K	-500K	-1.59M	-2.63M
Cash from Financing	-4.65M	10.23M	-375K	18.41M	-2.95M
Foreign Exchange Rate Adjustments	128K	-10K	-787K	323K	335K
Net Change in Cash	424K	368K	-12.16M	22.42M	-5.3M
Supplemental Items
Cash Interest Paid	-	74K	415K	2.92M	3.04M
Cash Income Tax Paid (Refund)	30K	160K	416K	2.85M	2.57M
Levered Free Cash Flow	7.04M	4.97M	-6.73M	14.11M	6.86M
Unlevered Free Cash Flow	7.13M	5.16M	-6.36M	15.93M	8.77M
Change In Net Working Capital	1.14M	5.03M	5.38M	784K	3.43M
Net Debt Issued / Repaid	-	10M	-	19.66M	-

Fiscal Period: September	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	-0.48	1.43	-7.82	2.04	-0.67
Return on Total Capital	-0.61	1.8	-9.97	2.53	-0.8
Return On Equity %	0.89	3.13	-21.95	-1.35	-9.67
Return on Common Equity	0.89	3.13	-21.95	-1.35	-9.67
Margin Analysis
Gross Profit Margin %	30.95	36.64	29.01	81.17	73.81
SG&A Margin	29.93	30.03	46.96	39.13	42.15
EBITDA Margin %	6.34	11.58	-12.95	10.65	5.35
EBITA Margin %	1.32	6.9	-17.69	7.09	1.47
EBIT Margin %	-1.32	3.95	-22.1	4.23	-1.54
Income From Continuing Operations Margin %	1.18	4.03	-27.29	-1.16	-9.15
Net Income Margin %	1.18	4.03	-27.29	-1.16	-9.15
Net Avail. For Common Margin %	1.18	4.03	-27.29	-1.16	-9.15
Normalized Net Income Margin	-0.64	2.26	-14.06	1.39	-1.89
Levered Free Cash Flow Margin	7.43	4.73	-6.74	10.64	5.44
Unlevered Free Cash Flow Margin	7.51	4.91	-6.36	12.01	6.96
Asset Turnover
Asset Turnover	0.58	0.58	0.57	0.77	0.69
Fixed Assets Turnover	3.04	3.23	3.16	4.43	4.42
Receivables Turnover (Average Receivables)	6.12	7	5.91	7.32	6.03
Inventory Turnover (Average Inventory)	12.52	10.47	7.64	1.87	2.2
Short Term Liquidity
Current Ratio	4.58	2.36	1.8	3.62	3.96
Quick Ratio	4.09	2.07	1.35	2.89	3.09
Operating Cash Flow to Current Liabilities	0.74	0.52	-0.54	0.44	0.01
Days Sales Outstanding (Average Receivables)	59.77	52.15	61.77	49.85	60.69
Days Outstanding Inventory (Average Inventory)	29.24	34.87	47.79	194.88	166.27
Average Days Payable Outstanding	9.84	8.93	11.81	39.97	31.71
Cash Conversion Cycle (Average Days)	79.18	78.09	97.74	204.75	195.25
Long Term Solvency
Total Debt/Equity	2.88	9.78	13.66	27.73	27.96
Total Debt / Total Capital	2.8	8.91	12.02	21.71	21.85
LT Debt/Equity	2.55	2.28	3.55	27	27.08
Long-Term Debt / Total Capital	2.48	2.07	3.12	21.14	21.17
Total Liabilities / Total Assets	22.34	28.01	31.55	35.44	33.41
EBIT / Interest Expense	-9.41	13.4	-36.93	1.61	-0.55
EBITDA / Interest Expense	49.71	41.85	-19.8	4.45	2.36
(EBITDA - Capex) / Interest Expense	22.11	24.82	-25.44	3.61	1.37
Total Debt / EBITDA	0.57	1.06	-1.25	2.14	3.98
Net Debt / EBITDA	-8.67	-1.94	0.35	-0.78	-0.82
Total Debt / (EBITDA - Capex)	1.28	1.78	-0.97	2.64	6.84
Net Debt / (EBITDA - Capex)	-19.49	-3.27	0.28	-0.96	-1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.21	10.83	-4.93	32.65	-4.91
Gross Profit, 1 Yr. Growth %	-13.17	31.22	-24.72	35.18	-13.54
EBITDA, 1 Yr. Growth %	-57.57	102.46	-206.33	-209.13	-52.22
EBITA, 1 Yr. Growth %	-86.79	480.86	-343.76	-153.17	-80.27
EBIT, 1 Yr. Growth %	-118.24	-432.13	-631.53	-125.37	-134.71
Earnings From Cont. Operations, 1 Yr. Growth %	-85.21	277.29	-743.71	-94.37	651.43
Net Income, 1 Yr. Growth %	-85.21	277.29	-743.71	-94.37	651.43
Normalized Net Income, 1 Yr. Growth %	-112.28	-489.54	-691.92	-113.08	-229.46
Diluted EPS Before Extra, 1 Yr. Growth %	-85.45	275	-753.33	-94.39	645.45
Accounts Receivable, 1 Yr. Growth %	-19.88	17.97	8.04	6.14	24.23
Inventory, 1 Yr. Growth %	32.55	13.31	74.84	25.55	2.22
Net Property, Plant and Equip., 1 Yr. Growth %	9.62	-0.26	-5.36	-5.74	-3.55
Total Assets, 1 Yr. Growth %	5.57	15.3	-18.62	17.29	-3.86
Tangible Book Value, 1 Yr. Growth %	10.31	-36.61	-31.15	28.38	-0.14
Common Equity, 1 Yr. Growth %	6.97	6.89	-22.62	10.63	-0.84
Cash From Operations, 1 Yr. Growth %	74.3	9.84	-211.92	-161.05	-97.64
Capital Expenditures, 1 Yr. Growth %	-38.8	43.8	-36.16	-13.41	19.67
Levered Free Cash Flow, 1 Yr. Growth %	-149.05	-29.45	-235.47	-311.03	-51.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-149.96	-27.56	-223.15	-350.46	-44.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8	2.5	2.65	12.3	12.31
Gross Profit, 2 Yr. CAGR %	5.52	6.74	-0.61	10.93	8.11
EBITDA, 2 Yr. CAGR %	-8.59	-7.31	46.73	7.72	-27.79
EBITA, 2 Yr. CAGR %	-39.95	-12.41	276.29	13.85	-67.61
EBIT, 2 Yr. CAGR %	27.96	-22.16	320.17	16.12	-70.32
Earnings From Cont. Operations, 2 Yr. CAGR %	-49.8	-25.29	392.82	-39.79	-34.95
Net Income, 2 Yr. CAGR %	-49.8	-25.29	392.82	-39.79	-34.95
Normalized Net Income, 2 Yr. CAGR %	-27.48	-30.83	380.18	-12.02	-58.85
Diluted EPS Before Extra, 2 Yr. CAGR %	-51.49	-26.15	394.97	-39.45	-35.32
Accounts Receivable, 2 Yr. CAGR %	24.61	-2.78	12.9	7.09	14.83
Inventory, 2 Yr. CAGR %	21.88	22.55	40.75	48.16	13.29
Net Property, Plant and Equip., 2 Yr. CAGR %	4.01	4.56	-2.85	-5.55	-4.65
Total Assets, 2 Yr. CAGR %	1.4	10.33	-3.13	-2.3	6.19
Tangible Book Value, 2 Yr. CAGR %	19.07	-16.38	-33.94	-5.98	13.23
Common Equity, 2 Yr. CAGR %	9.85	6.93	-9.06	-7.48	4.73
Cash From Operations, 2 Yr. CAGR %	-35.86	38.37	10.88	-17.34	-88
Capital Expenditures, 2 Yr. CAGR %	-36.46	-6.18	-4.19	-25.65	1.79
Levered Free Cash Flow, 2 Yr. CAGR %	-38.53	-41.18	-2.24	67.73	1.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-38.17	-39.84	-5.55	75.62	17.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.07	8.93	-0.04	11.81	6.24
Gross Profit, 3 Yr. CAGR %	-0.91	13.47	-4.99	54.19	2.09
EBITDA, 3 Yr. CAGR %	-22.53	19.15	-2.97	32.94	-17.85
EBITA, 3 Yr. CAGR %	-49.67	27.94	23.2	95.99	-36.53
EBIT, 3 Yr. CAGR %	-44.65	75.86	47.68	64.84	-22.35
Earnings From Cont. Operations, 3 Yr. CAGR %	-34.11	-1.67	53.15	11	39.66
Net Income, 3 Yr. CAGR %	-34.11	-1.67	53.15	11	39.66
Normalized Net Income, 3 Yr. CAGR %	-48.8	27	41.48	44.47	0.07
Diluted EPS Before Extra, 3 Yr. CAGR %	-34.9	-4.09	52.74	11.2	39.82
Accounts Receivable, 3 Yr. CAGR %	24.1	22.35	0.7	10.6	12.52
Inventory, 3 Yr. CAGR %	19.27	18.96	37.96	35.49	30.92
Net Property, Plant and Equip., 3 Yr. CAGR %	12.44	2.57	1.14	-3.82	-4.89
Total Assets, 3 Yr. CAGR %	7.3	5.84	-0.32	3.25	-2.82
Tangible Book Value, 3 Yr. CAGR %	12.45	-3.5	-21.62	-17.56	-4.07
Common Equity, 3 Yr. CAGR %	5.52	8.85	-4	-2.92	-5.32
Cash From Operations, 3 Yr. CAGR %	-0.1	-23.26	28.92	-9.13	-74.74
Capital Expenditures, 3 Yr. CAGR %	-17.05	-16.57	-17.48	-7.37	-12.87
Levered Free Cash Flow, 3 Yr. CAGR %	5.83	-35.64	-22.32	26.06	11.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.25	-34.81	-23.62	30.73	19.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.91	8.06	6.45	10.27	4.73
Gross Profit, 5 Yr. CAGR %	-4.58	-1.69	-0.79	32.49	22.44
EBITDA, 5 Yr. CAGR %	-25.61	-14.35	0.02	14.44	-13.79
EBITA, 5 Yr. CAGR %	-44.73	-21.24	12.54	22.11	-27.8
EBIT, 5 Yr. CAGR %	-44.42	-28.04	24.52	48.96	-22.28
Earnings From Cont. Operations, 5 Yr. CAGR %	-37.68	-15.76	47.35	-19.19	8.74
Net Income, 5 Yr. CAGR %	-37.68	-15.76	47.35	-19.19	8.74
Normalized Net Income, 5 Yr. CAGR %	-47.2	-29.04	25.35	9.66	-13.67
Diluted EPS Before Extra, 5 Yr. CAGR %	-38.37	-16.96	46.55	-20.2	8.32
Accounts Receivable, 5 Yr. CAGR %	13.01	18.81	19.49	16	6.13
Inventory, 5 Yr. CAGR %	14.9	13.56	27.44	29.87	27.5
Net Property, Plant and Equip., 5 Yr. CAGR %	20.25	10.66	6.05	-0.76	-1.22
Total Assets, 5 Yr. CAGR %	11.32	7.93	3	2.5	2.24
Tangible Book Value, 5 Yr. CAGR %	2.24	-0.11	-9.1	-4.5	-9.2
Common Equity, 5 Yr. CAGR %	7.36	5.57	-0.57	2	-0.6
Cash From Operations, 5 Yr. CAGR %	-1.38	-9.37	4.15	-20.95	-50.13
Capital Expenditures, 5 Yr. CAGR %	14.36	-8.41	-12.13	-20.33	-10.25
Levered Free Cash Flow, 5 Yr. CAGR %	-14.27	-24.31	2.53	-5.42	-13.73
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.07	-23.73	1.36	-3.1	-9.27